Literature DB >> 16255748

Noninvasive risk stratification of subjects with a Brugada-type electrocardiogram and no history of cardiac arrest.

Takanori Ikeda1, Mitsuaki Takami, Kaoru Sugi, Yuka Mizusawa, Harumizu Sakurada, Hideaki Yoshino.   

Abstract

BACKGROUND: Recent studies suggest that the Brugada-type electrocardiogram (ECG) is much more prevalent than the manifest Brugada syndrome. Although invasive electrophysiologic investigations have been proposed as a risk stratifier, their value is controversial, and alternative noninvasive techniques may be preferred. We sought a noninvasive strategy to detect a high-risk group in a long-term follow-up study of subjects with a Brugada-type ECG, and no history of cardiac arrest.
METHODS: This study enrolled 124 consecutive subjects with a Brugada-type ECG. Prognostic indices included: age, sex, a family history of sudden death, syncopal episodes, a spontaneous coved-type ST-segment elevation, maximal magnitude of ST-segment elevation, a spontaneous change in ST segment, a mean QRS duration, maximal QT interval, QT dispersion, late potentials (LP) by signal-averaged ECG, and microvolt T-wave alternans.
RESULTS: Of the 124 subjects, 20 consenting subjects had an implantable defibrillator before follow-up. During a 40 +/- 19-month follow-up, 12 subjects (9.7%) reached one of the endpoints (sudden death or ventricular tachyarrhythmia). Of the 12 risk indices, a family history of sudden death, syncopal episodes, a spontaneous coved-type ST-segment elevation, a spontaneous change in ST segment, and LP had significant values. In multivariate analysis, a spontaneous change in ST segment had the most significance (a relative hazard, 9.2; P = 0.036). Combined assessment of this index and other significant indices obtained higher positive predictive values (43-71%).
CONCLUSIONS: A spontaneous change in ST segment is associated with the highest risk for subsequent events in subjects with a Brugada-type ECG. The presence of syncopal episodes, a history of familial sudden death, and/or LP may increase its value.

Entities:  

Mesh:

Year:  2005        PMID: 16255748      PMCID: PMC6932722          DOI: 10.1111/j.1542-474X.2005.00055.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  24 in total

1.  Prevalence of the brugada syndrome in an apparently healthy population.

Authors:  J S Hermida; J L Lemoine; F B Aoun; G Jarry; J L Rey; J C Quiret
Journal:  Am J Cardiol       Date:  2000-07-01       Impact factor: 2.778

Review 2.  The Brugada syndrome: diagnostic criteria and cellular mechanisms.

Authors:  C Antzelevitch
Journal:  Eur Heart J       Date:  2001-03       Impact factor: 29.983

3.  Late potentials and the Brugada syndrome.

Authors:  Charles Antzelevitch
Journal:  J Am Coll Cardiol       Date:  2002-06-19       Impact factor: 24.094

4.  The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome.

Authors:  K Matsuo; T Kurita; M Inagaki; M Kakishita; N Aihara; W Shimizu; A Taguchi; K Suyama; S Kamakura; K Shimomura
Journal:  Eur Heart J       Date:  1999-03       Impact factor: 29.983

5.  The prevalence, incidence and prognostic value of the Brugada-type electrocardiogram: a population-based study of four decades.

Authors:  K Matsuo; M Akahoshi; E Nakashima; A Suyama; S Seto; M Hayano; K Yano
Journal:  J Am Coll Cardiol       Date:  2001-09       Impact factor: 24.094

6.  Prevalence of asymptomatic ST segment elevation in right precordial leads with right bundle branch block (Brugada-type ST shift) among the general Japanese population.

Authors:  M Furuhashi; K Uno; K Tsuchihashi; D Nagahara; M Hyakukoku; T Ohtomo; S Satoh; T Nishimiya; K Shimamoto
Journal:  Heart       Date:  2001-08       Impact factor: 5.994

7.  Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3.

Authors:  Josep Brugada; Ramon Brugada; Charles Antzelevitch; Jeffrey Towbin; Koonlawee Nademanee; Pedro Brugada
Journal:  Circulation       Date:  2002-01-01       Impact factor: 29.690

8.  Effects of glucose-induced insulin secretion on ST segment elevation in the Brugada syndrome.

Authors:  Mitsuhiro Nishizaki; Harumizu Sakurada; Takashi Ashikaga; Noriyoshi Yamawake; Hiroyuki Fujii; Masataka Arita; Mitsuaki Isobe; Masayasu Hiraoka
Journal:  J Cardiovasc Electrophysiol       Date:  2003-03

Review 9.  Brugada syndrome: current clinical aspects and risk stratification.

Authors:  Takanori Ikeda
Journal:  Ann Noninvasive Electrocardiol       Date:  2002-07       Impact factor: 1.468

10.  Electrophysiologic investigation in Brugada syndrome; yield of programmed ventricular stimulation at two ventricular sites with up to three premature beats.

Authors:  L Eckardt; P Kirchhof; E Schulze-Bahr; S Rolf; M Ribbing; P Loh; H-J Bruns; A Witte; P Milberg; M Borggrefe; G Breithardt; T Wichter; W Haverkamp
Journal:  Eur Heart J       Date:  2002-09       Impact factor: 29.983

View more
  27 in total

Review 1.  Usefulness of T-wave alternans in sudden death risk stratification and guiding medical therapy.

Authors:  Tuomo Nieminen; Richard L Verrier
Journal:  Ann Noninvasive Electrocardiol       Date:  2010-07       Impact factor: 1.468

Review 2.  The year 2005 in electrocardiology.

Authors:  Shlomo Stern
Journal:  Ann Noninvasive Electrocardiol       Date:  2006-04       Impact factor: 1.468

3.  Comparison of quantitative T-wave alternans profiles of healthy subjects and ICD patients.

Authors:  Euler de Vilhena Garcia; Nelson Samesima; Horácio G Pereira Filho; Cristina M Quadros; Luis Tenório Cavalcante da Silva; Martino Martinelli Filho; Maria Luciana Zacharias Hannouche; Wilson Mathias; Carlos Alberto Pastore
Journal:  Ann Noninvasive Electrocardiol       Date:  2009-04       Impact factor: 1.468

Review 4.  T-wave alternans: reviewing the clinical performance, understanding limitations, characterizing methodologies.

Authors:  Euler de Vilhena Garcia
Journal:  Ann Noninvasive Electrocardiol       Date:  2008-10       Impact factor: 1.468

5.  Genotype-phenotype relationship and risk stratification in loss-of-function SCN5A mutation carriers.

Authors:  Tomas Robyns; Dieter Nuyens; Bert Vandenberk; Cuno Kuiperi; Anniek Corveleyn; Jeroen Breckpot; Christophe Garweg; Joris Ector; Rik Willems
Journal:  Ann Noninvasive Electrocardiol       Date:  2018-04-30       Impact factor: 1.468

Review 6.  J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

Authors:  Charles Antzelevitch; Gan-Xin Yan; Michael J Ackerman; Martin Borggrefe; Domenico Corrado; Jihong Guo; Ihor Gussak; Can Hasdemir; Minoru Horie; Heikki Huikuri; Changsheng Ma; Hiroshi Morita; Gi-Byoung Nam; Frederic Sacher; Wataru Shimizu; Sami Viskin; Arthur A M Wilde
Journal:  Europace       Date:  2017-04-01       Impact factor: 5.214

Review 7.  J wave syndromes: molecular and cellular mechanisms.

Authors:  Charles Antzelevitch
Journal:  J Electrocardiol       Date:  2013-09-06       Impact factor: 1.438

Review 8.  J-Wave syndromes expert consensus conference report: Emerging concepts and gaps in knowledge.

Authors:  Charles Antzelevitch; Gan-Xin Yan; Michael J Ackerman; Martin Borggrefe; Domenico Corrado; Jihong Guo; Ihor Gussak; Can Hasdemir; Minoru Horie; Heikki Huikuri; Changsheng Ma; Hiroshi Morita; Gi-Byoung Nam; Frederic Sacher; Wataru Shimizu; Sami Viskin; Arthur A M Wilde
Journal:  Heart Rhythm       Date:  2016-07-13       Impact factor: 6.343

9.  Risk stratification in young patients with channelopathies.

Authors:  N Sreeram; U Trieschmann; M Khalil; M Emmel
Journal:  Indian Pacing Electrophysiol J       Date:  2010-06-05

10.  Brugada syndrome: Controversies in Risk stratification and Management.

Authors:  Lm Nunn; J Bhar-Amato; Pd Lambiase
Journal:  Indian Pacing Electrophysiol J       Date:  2010-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.